← Home / Zoetis Inc. (ZTS)
Stock Analysis

Zoetis Inc. (ZTS)

ZTS
ZTS · Healthcare • Drug Manufacturers - Specialty & Generic
76.73 -1.30%
Track ZTS in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when ZTS price is:
52W Range Position
6%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-08-24 17:52 UTC
WOI Investment Thesis
Mixed
Current market structure would strengthen above 80.17. Holding above 71.92 preserves the current price structure.
⚖️
✓
Fundamentals
Weak / Strong
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
71.92
↗
Break Above
Primary setup confirms above this trigger.
101.00
🎯
Next Objective
No defined objective is currently available for the primary downtrend breakout.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
6
●
Management / Board
MEDIUM
ZTS board and management update
Appointment of James Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer On August 6, 2026, Zoetis Inc.
8-K Filing • SEC EDGAR
AUG
6
●
Financial Results
HIGH
ZTS reports financial results
(Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S.
8-K Filing • SEC EDGAR
MAY
22
●
Management / Board
MEDIUM
ZTS board and management update
of this Current Report on Form 8-K, on May 20, 2026, the Company held the Annual Meeting.
8-K Filing • SEC EDGAR
What's Driving ZTS?
▲ Technical confirmation is pending
Momentum is Neutral. Watch Above 101.00 for setup confirmation. Structure risk is Below 71.92.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 71.92
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
A technical structure is developing but has not yet reached confirmed active status.
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
101.00
RSI(14)
52.3
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 71.92 and resistance around 80.17. The chart still needs to reclaim resistance to improve meaningfully, while any loss of support would keep weakness in control.
Price Chart
ZTS — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-21
Fair
Fair valuation
Strong quality metrics make the valuation look balanced rather than simply cheap.
Market Cap
$31.0B
Company size
EV
$38.6B
Debt-adjusted value
P/E
12.2
Low multiple
P/S
3.3
Low sales multiple
P/B
10.2
Premium
EV/Sales
4.0
Balanced
EV/EBIT
9.9
Low multiple
P/FCF
15.4
Low multiple
FCF Yield
6.51%
Cash return
Not financial advice
Business Lens
Improving financial execution
Financial conditions require selective monitoring.
↗
Revenue Growth
Weak
●
Profitability
Strong
≈
Cash Flow
Healthy
⚖
Balance Sheet
Pressured
💵 Revenue
2.47B
↘ Weak
📈 Net Income
691.00M
↗ Strong
🧮 EPS (Basic)
1.65
↗ Strong
Zoetis Inc.
Healthcare • Drug Manufacturers - Specialty & Generic
You Might Also Like